
Chemical and Pharmaceutical Bulletin p. 2362 - 2369 (1992)
Update date:2022-08-02
Topics:
Sakoda
Kamikawaji
Seto
The effect of the 3-carboxylic-ester variation in 2,2-dimethyltrimethylene 3-alkoxycarbonyl-4-aryl-1,4-dihydro-2,6-dimethyl-5-pyridinephosphonate s (1) was investigated with relation to the calcium-antagonistic and antihypertensive activities: the analogs containing the alkyl groups of not more than 12 carbons and an amino functionality in the carboxylic-ester moiety were synthesized to be examined for biological activities. Among them, 2-[benzyl(phenyl)amino]-ethyl 5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-di methyl-4-(3-nitrophenyl)-3-pyridine-carboxylate hydrochloride ethanol (NZ-105) showed particularly beneficial activities and was selected for further pharmacological studies and clinical development. Some aspects of the structure-activity relationships and solid-state structure of NZ-105 by X-ray crystallographic analysis were described.
View Morejiangsu hualin chemical co.,ltd.
Contact:86-25-87787402
Address:jaingsu,china
Contact:+86-21-56338808
Address:799 Dunhuang Road, Putuo
Lianyungang Ningkang Chemical Co., Ltd
Contact:.+86-518-88588008
Address:http://www.chemnk.com
Shanghai doly chemical Co.,Ltd
Contact:+86-21-34716221
Address:No.328,WuHe Roard,MinHang,ShangHai China
jintan yufan Medicine Raw materials Co.,Ltd.(expird)
Contact:86-519-82808282
Address:6th,Jincheng Huangzhuang
Doi:10.1055/s-0029-1218372
(2009)Doi:10.1016/S0040-4020(01)89790-8
(1988)Doi:10.1002/chem.200901842
(2010)Doi:10.1007/BF00475685
(1988)Doi:10.1055/s-1988-27729
(1988)Doi:10.1246/cl.2010.24
(2010)